Evaluation of Use of Brain Activity Monitoring for Prediction of Migraine Attacks

A Feasibility Study for Examination the Use of Brain Prefrontal Activity Monitoring, for Early Detection of Migraine Attack

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02583581

Enrollment

Registered

2015-10-22

Start date

2015-10-31

Completion date

2018-02-28

Last updated

2017-06-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Migraine

Brief summary

This study evaluates the use of brain activity monitoring for prediction of migraine attacks in an expected time scale of 12-48 hours prior to the migraine attack.

Detailed description

The study will be conducted in one are. Participants diagnosed with migraine, will be evaluated for their EEG characteristics as well as daily migraine related clinical and general status. Participants' monitoring will be conducted for 20 times for a duration of one month.

Interventions

DEVICEEEG monitoring (MindWave by NeuroSky)

EEG evaluation will be conducted for duration of 10 minutes. 5 minutes without auditory stimulation and 5 minutes with auditory stimulation performed using standard headphone or earphones to reduce external noises.

DEVICEEEG monitoring (EPOC by Emotiv)

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

DIAGNOSTIC

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to 50 Years

Healthy volunteers

Inclusion criteria

* Diagnosed with migraine by a neurologist. * Male or Female, aged 18 -50 years. * Able and willing to comply with all study requirements. * Having 3-10 migraine attacks per month.

Exclusion criteria

* Diagnosed with chronic pain, neurological or psychiatric disorders. * Current or past use of anti-depressants. * A user of recreational or illicit drugs or has had a recent history of drug or alcohol abuse or dependence. * History of seizures * Head injury with consciousness loss in the last three months. * Diagnosed as ADHD and/or use of Ritalin. * Hearing disorder and/or known ear drum impairment. * Having migraine attacks occurring only during the menstruation.

Design outcomes

Primary

Measure	Time frame	Description
Measurements of brain electrical signal in Micro volt.	1 months	Measurements of brain electrical signal in Micro volt will be quantified by an algorithm and correlated to reported migraine cycle (as reported by migraine patients in questionnaires).

Countries

Israel

Contacts

Primary ContactYael Rozen, Dr.

yael@brainmarc.com972-6660677

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026